Brokerage firm Deutsche Bank Maintains its rating on VWR Corp(NASDAQ:VWR). In a research note issued to the investors, the brokerage major Raises the price-target to $32.00 per share. The shares have been rated Buy. The rating by Deutsche Bank was issued on Aug 5, 2016.
In a different note, On Aug 5, 2016, Barclays said it Maintains its rating on VWR Corp. In the research note, the firm Raises the price-target to $30.00 per share. The shares have been rated ‘Overweight’ by the firm. On Aug 5, 2016, Citigroup said it Maintains its rating on VWR Corp. In the research note, the firm Raises the price-target to $30.00 per share. The shares have been rated ‘Neutral’ by the firm.
VWR Corp (VWR) shares turned negative on Wednesdays trading session with the shares closing down -0.29 points or -0.99% at a volume of 7,33,772. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $29.43. The peak price level was also seen at $29.43 while the days lowest was $28.84. Finally the shares closed at $29.03. The 52-week high of the shares is $31.75 while the 52-week low is $21.56. According to the latest information available, the market cap of the company is $3,817 M.
VWR Corp(VWR) last announced its earnings results on Aug 4, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $1.15B. Analysts had an estimated revenue of $1.14B. Earnings per share were $0.42. Analysts had estimated an EPS of $0.41.
Several Insider Transactions has been reported to the SEC. On Jul 15, 2016, Manuel Brocke-benz (CEO) purchased 333 shares at $29.84 per share price.Also, On May 25, 2016, Nicholas W Alexos (director 10% owner) sold 8,000,000 shares at $27.25 per share price.On May 25, 2016, Timothy P Sullivan (director 10% owner) sold 8,000,000 shares at $27.25 per share price, according to the Form-4 filing with the securities and exchange commission.
VWR Corporation (VWR) is a provider of laboratory products services and solutions to the life science general research and applied markets. The Company operates in two segments: North Central and South America (Americas) and Europe Middle East Africa and Asia Pacific (EMEA-APAC). It has a presence in Europe and North America with respect to the laboratory products market. It also has operations in Asia-Pacific and other markets to support its multinational customers across the globe. The Company offers a portfolio of and private label laboratory products and a range of services including custom manufacturing. The Company’s portfolio includes chemicals reagents consumables durable products and scientific equipment and instruments. The Company’s branded and private label product portfolio includes service offerings marketed under the VWRCATALYST brand including sourcing and procurement logistics chemical and equipment tracking and sample management.